Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Receivables (2016 - 2025)

Historic Receivables for Eastman Chemical (EMN) over the last 17 years, with Q4 2025 value amounting to $999.0 million.

  • Eastman Chemical's Receivables fell 1476.11% to $999.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $999.0 million, marking a year-over-year decrease of 1476.11%. This contributed to the annual value of $999.0 million for FY2025, which is 1476.11% down from last year.
  • Eastman Chemical's Receivables amounted to $999.0 million in Q4 2025, which was down 1476.11% from $1.3 billion recorded in Q3 2025.
  • Eastman Chemical's 5-year Receivables high stood at $1.7 billion for Q2 2021, and its period low was $999.0 million during Q4 2025.
  • For the 5-year period, Eastman Chemical's Receivables averaged around $1.4 billion, with its median value being $1.3 billion (2024).
  • Its Receivables has fluctuated over the past 5 years, first soared by 3122.17% in 2021, then plummeted by 2791.72% in 2023.
  • Over the past 5 years, Eastman Chemical's Receivables (Quarter) stood at $1.2 billion in 2021, then fell by 10.49% to $1.0 billion in 2022, then increased by 9.9% to $1.2 billion in 2023, then increased by 1.56% to $1.2 billion in 2024, then fell by 14.76% to $999.0 million in 2025.
  • Its last three reported values are $999.0 million in Q4 2025, $1.3 billion for Q3 2025, and $1.3 billion during Q2 2025.